Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Human Natural Killer Cell
Email alerts
Human Natural Killer Cell
Potent
ex vivo
expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
Xiaokui
Zhang
,
Lin
Kang
,
Ivana
Djuretic
,
Eric
Law
,
Vanessa
Voskinarian-Berse
,
Jeffrey
Harris
,
Uri
Herzberg
,
Wolfgang
Hofgartner
,
Robert
Hariri
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P62;
DOI:
10.1186/2051-1426-3-S2-P62
What's new in IL-12? Combination!
Chris E
Lawrence
,
Mark
Rubinstein
,
Zoya
Gluzman-Poltorak
,
Vladimir
Vainstein
,
Lena A
Basile
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P363;
DOI:
10.1186/2051-1426-3-S2-P363
Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
Steven
Grossenbacher
,
Erik
Ames
,
Stephanie
Mac
,
Yuyou
Duan
,
Syed
Azeem
,
Robert
Canter
,
William
Murphy
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P17;
DOI:
10.1186/2051-1426-3-S2-P17
Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability
Lazar
Vujanovic
,
Elizabeth
Stahl
,
Angela
Pardee
,
Simon
Watkins
,
Gregory
Gibson
,
Lisa H
Butterfield
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P289;
DOI:
10.1186/2051-1426-3-S2-P289
Single-cell quantification of functional outcomes of CD16 ligation in NK cells by Fc-engineered antibodies
Gabrielle
Romain
,
Vladimir V
Senyukov
,
Ivan
Liadi
,
William
Kelton
,
George
Georgiou
,
Dean A
Lee
,
Navin
Varadarajan
Journal for ImmunoTherapy of Cancer
Nov 2013,
1
(Suppl 1)
O5;
DOI:
10.1186/2051-1426-1-S1-O5
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(531)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(930)
Commentary/Editorials
(139)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(53)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(208)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(401)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(142)
Reviews
(238)
Open access
(4833)
Press releases